Envometinib is a dual MEK inhibitor that utilizes Deep Cyclic Inhibition (DCI) as its primary mechanism of action. It demonstrates significant antitumor activity across various in vivo models, making it a valuable tool for cancer research. Envometinib is particularly relevant for studies involving RAS and RAF mutated cancers, such as colorectal cancer and melanoma.
Envometinib is a dual MEK inhibitor that utilizes Deep Cyclic Inhibition (DCI) as its primary mechanism of action. It demonstrates significant antitumor activity across various in vivo models, making it a valuable tool for cancer research. Envometinib is particularly relevant for studies involving RAS and RAF mutated cancers, such as colorectal cancer and melanoma.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
